Eps Summary of UCB SA

UCB SA's latest annual eps in 2023 was 1.76 EUR , down -17.73% from previous year.
UCB SA's latest quarterly eps in 2024 Q1 was 0.53 EUR , up 211.76% from previous quarter.
UCB SA reported an annual eps of 2.20 EUR in 2022, down -60.71% from previous year.
UCB SA reported an annual eps of 5.60 EUR in 2021, up 44.7% from previous year.
UCB SA reported a quarterly eps of 0.53 EUR for 2024 Q2, down 0.0% from previous quarter.
UCB SA reported a quarterly eps of 0.08 EUR for 2023 Q3, down -95.02% from previous quarter.

Annual Eps Chart of UCB SA (2023 - 2002)

Historical Annual Eps of UCB SA (2023 - 2002)

Year	Eps	Eps Growth
2023	1.76 EUR	-17.73%
2022	2.20 EUR	-60.71%
2021	5.60 EUR	44.7%
2020	3.87 EUR	-8.51%
2019	4.23 EUR	-50.18%
2018	8.49 EUR	6.13%
2017	8.00 EUR	44.93%
2016	5.52 EUR	-15.08%
2015	6.50 EUR	195.45%
2014	2.20 EUR	25.0%
2013	1.76 EUR	-36.69%
2012	2.78 EUR	3.73%
2011	2.68 EUR	135.09%
2010	1.14 EUR	-80.0%
2009	5.70 EUR	1087.5%
2008	0.48 EUR	-73.03%
2007	1.78 EUR	-64.96%
2006	5.08 EUR	-51.71%
2005	10.52 EUR	131.72%
2004	4.54 EUR	-1.94%
2003	4.63 EUR	25.47%
2002	3.69 EUR	0.0%

Year	Eps	Eps Growth
2024 Q1	0.53 EUR	211.76%
2024 Q2	0.53 EUR	0.0%
2023 Q3	0.08 EUR	-95.02%
2023 Q1	0.80 EUR	700.0%
2023 FY	- EUR	-17.73%
2023 Q4	0.17 EUR	108.33%
2023 Q2	1.64 EUR	105.0%
2022 Q4	0.10 EUR	0.0%
2022 Q2	2.10 EUR	103.88%
2022 Q1	1.03 EUR	-60.08%
2022 FY	- EUR	-60.71%
2021 FY	- EUR	44.7%
2021 Q4	2.58 EUR	104.76%
2021 Q3	1.26 EUR	-58.28%
2021 Q2	3.02 EUR	106.85%
2021 Q1	1.46 EUR	-25.13%
2020 Q2	1.92 EUR	106.45%
2020 Q4	1.95 EUR	103.13%
2020 Q1	0.93 EUR	-53.96%
2020 FY	- EUR	-8.51%
2020 Q3	0.96 EUR	-50.0%
2019 Q4	2.02 EUR	0.0%
2019 FY	- EUR	-50.18%
2019 Q1	1.10 EUR	0.0%
2019 Q2	2.20 EUR	100.0%
2018 Q2	1.46 EUR	0.0%
2018 FY	- EUR	6.13%
2018 Q1	1.46 EUR	71.76%
2017 FY	- EUR	44.93%
2017 Q2	1.14 EUR	0.0%
2017 Q1	1.14 EUR	83.87%
2017 Q4	0.85 EUR	0.0%
2017 Q3	0.85 EUR	-25.44%
2016 Q1	0.82 EUR	1159.6%
2016 FY	- EUR	-15.08%
2016 Q3	0.62 EUR	-24.39%
2016 Q4	0.62 EUR	0.0%
2016 Q2	0.82 EUR	0.0%
2015 Q4	0.07 EUR	0.0%
2015 Q1	0.62 EUR	742.39%
2015 Q2	0.62 EUR	0.0%
2015 Q3	0.07 EUR	-89.5%
2015 FY	- EUR	195.45%
2014 Q1	0.23 EUR	278.29%
2014 Q3	0.07 EUR	-68.0%
2014 Q2	0.23 EUR	0.0%
2014 Q4	0.07 EUR	0.0%
2014 FY	- EUR	25.0%
2013 Q3	0.06 EUR	-59.47%
2013 Q1	0.15 EUR	0.0%
2013 FY	- EUR	-36.69%
2013 Q4	0.06 EUR	0.0%
2013 Q2	0.15 EUR	0.0%
2012 FY	- EUR	3.73%
2011 FY	- EUR	135.09%
2010 FY	- EUR	-80.0%
2009 FY	- EUR	1087.5%
2008 FY	- EUR	-73.03%
2007 FY	- EUR	-64.96%
2006 FY	- EUR	-51.71%
2005 FY	- EUR	131.72%
2004 FY	- EUR	-1.94%
2003 FY	- EUR	25.47%
2002 FY	- EUR	0.0%

Peer Eps Comparison of UCB SA

Name	Eps	Eps Difference
Burzynski Research Institute, Inc.	-0.01 USD	17354.902%
Santhera Pharmaceuticals Holding AG	5.95 USD	70.42%
Neon Bloom, Inc.	-0.00 USD	117433.333%
Nascent Biotech, Inc.	-0.01 USD	13234.328%
Qrons Inc.	-0.06 USD	3118.868%
Regen BioPharma, Inc.	0.26 USD	-576.923%
Evofem Biosciences, Inc.	10.35 USD	82.995%
BioStem Technologies, Inc.	-0.62 USD	383.871%
Skye Bioscience, Inc.	-5.37 USD	132.775%
ProtoKinetix, Incorporated	-0.01 USD	17700.0%
Rebus Holdings, Inc.	-0.03 USD	5582.866%
CSL Limited	2.73 USD	35.531%
Northwest Biotherapeutics, Inc.	-0.06 USD	3160.87%
Capstone Therapeutics Corp.	-36.39 USD	104.836%
Acro Biomedical Co., Ltd.	-0.26 USD	776.923%
Adynxx, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	-2.27 USD	177.533%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	103.466%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	3517.476%
SQZ Biotechnologies Company	-2.76 USD	163.768%
Intellipharmaceutics International Inc.	-0.09 USD	2113.73%
Propanc Biopharma, Inc.	-0.02 USD	7526.16%
Mesoblast Limited	-0.09 USD	2075.309%
Marizyme, Inc.	-1.44 USD	222.222%
Genus plc	0.12 USD	-1366.667%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	175.536%
Pharming Group N.V.	-0.02 USD	11031.677%
Therapeutic Solutions International, Inc.	-0.00 USD	251528.571%
CNBX Pharmaceuticals Inc.	-0.42 USD	519.048%
Nymox Pharmaceutical Corporation	-0.10 USD	1923.834%
ContraFect Corporation	-124.97 USD	101.408%
PsyBio Therapeutics Corp.	-0.04 USD	4290.476%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	14766.667%
IMV Inc.	-4.37 USD	140.275%
AXIM Biotechnologies, Inc.	-0.04 USD	5071.751%
MultiCell Technologies, Inc.	-0.00 USD	1760100.0%
ONE Bio Corp.	1.43 USD	-23.077%
Accustem Sciences Inc.	-0.34 USD	617.647%
RVL Pharmaceuticals plc	-0.58 USD	403.448%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	-0.12 USD	1566.667%
Q BioMed Inc.	-0.08 USD	2353.521%
Emmaus Life Sciences, Inc.	-0.07 USD	2603.556%
Mosaic ImmunoEngineering Inc.	-0.33 USD	633.333%
Biomind Labs Inc.	-0.02 USD	10964.198%
American Oriental Bioengineering, Inc.	-781.24 USD	100.225%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	23883.784%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	8944.221%
GlobeStar Therapeutics Corporation	-0.00 USD	73433.333%
THC Farmaceuticals, Inc.	-0.00 USD	220100.0%
Curative Biotechnology, Inc.	-0.01 USD	20100.0%
GB Sciences, Inc.	-0.00 USD	43026.829%
Alpha Cognition Inc.	-0.15 USD	1273.333%
HST Global, Inc.	-0.03 USD	6408.244%
Wesana Health Holdings Inc.	-0.05 USD	3612.974%
Halberd Corporation	-0.00 USD	1760100.0%
Enzolytics Inc.	-0.00 USD	251528.571%
Agentix Corp.	-0.04 USD	5128.571%
Resverlogix Corp.	-0.01 USD	12494.366%
Nuo Therapeutics, Inc.	-0.08 USD	2434.218%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	-5.16 USD	134.109%
Enzon Pharmaceuticals, Inc.	0.00 USD	-135284.615%
Endonovo Therapeutics, Inc.	0.03 USD	-6911.952%
RespireRx Pharmaceuticals Inc.	-0.04 USD	5029.972%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	8900.0%
AVAX Technologies, Inc.	-0.05 USD	3365.306%
Zenith Capital Corp.	-0.07 USD	2617.883%
Genscript Biotech Corporation	-0.05 USD	3976.652%
Ember Therapeutics, Inc.	-0.01 USD	28036.508%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	146.684%
WPD Pharmaceuticals Inc.	-0.00 USD	352100.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	2027.711%
Kadimastem Ltd	-0.78 USD	325.641%
Helix BioMedix, Inc.	-4.70 USD	137.447%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	-0.01 USD	14889.916%
LadRx Corporation	0.68 USD	-158.824%
Cell Source, Inc.	-0.17 USD	1135.294%
Regen BioPharma, Inc.	0.29 USD	-506.897%
NovAccess Global Inc.	-0.23 USD	865.217%
Affymax, Inc.	-0.39 USD	551.282%
Itoco Inc.	-0.01 USD	23257.895%
Rasna Therapeutics, Inc.	-0.01 USD	17700.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	70500.0%
Mobile Lads Corp.	-0.01 USD	31528.571%
CytoDyn Inc.	-0.05 USD	3427.032%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	352100.0%
NanoSphere Health Sciences Inc.	-0.02 USD	8027.928%
Alseres Pharmaceuticals, Inc.	-153.67 USD	101.145%
SYBLEU INC	-0.02 USD	10157.143%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	12494.366%
International Stem Cell Corporation	-0.02 USD	10831.707%
Bioxytran, Inc.	-0.03 USD	5617.241%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	-0.00 USD	1760100.0%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	-7.99 USD	122.028%
Adhera Therapeutics, Inc.	-1.18 USD	249.153%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	-0.03 USD	5276.471%
Innovation Pharmaceuticals Inc.	-0.01 USD	28036.508%
Neutra Corp.	-0.00 USD	1760100.0%
Windtree Therapeutics, Inc.	-94.23 USD	101.868%
PureTech Health plc	-2.38 USD	173.95%
Coeptis Therapeutics, Inc.	-0.83 USD	312.048%
IXICO plc	-0.02 USD	7313.115%
IntelGenx Technologies Corp.	-0.06 USD	3198.592%
Gelesis Holdings, Inc.	-1.35 USD	230.37%
CSL Limited	5.47 USD	67.824%
Cellectis S.A.	-1.77 USD	199.435%

Global Stocks Search

UCB SA (UCBJF)

Eps Summary of UCB SA

Annual Eps Chart of UCB SA (2023 - 2002)

Historical Annual Eps of UCB SA (2023 - 2002)

Peer Eps Comparison of UCB SA